Home
Investors
Sientra.com
Overview
News
Events
Financial Info
Quarterly Reports
SEC Filings
Stock Info
Quote & Chart
Analyst Coverage
Governance
Documents & Charters
Management
Board of Directors
Committee Composition
Resources
FAQs
E-mail Alerts
RSS Feeds
contact IR
News
Elieen, Actual Sientra Patient
Normal
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 10, 2018
Sientra Reports Third Quarter 2018 Financial Results
November 6, 2018
Sientra to Participate in Upcoming Investor Conferences
October 31, 2018
Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018
October 23, 2018
Sientra Announces FULL CIRCLE Grant Recipients
October 23, 2018
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 17, 2018
Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations
August 15, 2018
Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 10, 2018
Sientra Reports Second Quarter 2018 Financial Results
August 7, 2018
Sientra to Launch State-of-the-Art Innovation Facility
July 31, 2018
Sientra to Present at the Canaccord 38th Annual Growth Stock Conference
July 25, 2018
Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018
July 24, 2018
Sientra to Present at the William Blair 38th Annual Growth Stock Conference
June 4, 2018
Sientra Reports First Quarter 2018 Financial Results
May 9, 2018
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
May 7, 2018
Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018
May 4, 2018
Sientra Announces Pricing of Upsized Public Offering of Common Stock
May 3, 2018
Sientra Commences Public Offering of Common Stock
April 30, 2018
Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting
April 25, 2018
Sientra Receives FDA Approval of PMA Supplement
April 18, 2018
Sientra Reports Fourth Quarter and Full Year 2017 Financial Results
March 13, 2018
Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2018
March 2, 2018
Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual Meeting
February 16, 2018
Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility
January 30, 2018
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 25, 2018
Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue
January 8, 2018
Nasdaq: SIEN
Stock Quote:
NASD
$
2.78
+
0.18
Volume
79,336
Previous Close
2.60
Intraday High
2.84
Intraday Low
2.60
Pricing delayed 20 minutes
Price
Change
% Change
+
6.92%
52 Week High
8.88
52 Week Low
1.25
Today's Open
2.65
Sep 29, 2023 04:00 PM
Email Alerts
Email:
*
Subscription Preferences
*
Press Release
SEC Filing
Event
EOD Stock Quote
Enter the code shown above.
Investor Contact
Sientra Investor Relations
ir@sientra.com
Privacy Statement
|
Terms of use
|
Safety
|
Compliance
|
Resources
|
Patents
|
Contact Us
|
Careers
© 2021 Sientra, Inc. All rights reserved.